|
| 37424259 | Epstein-Barr virus-positive monoclonal lymphoplasmacytic proliferation associated with neurosyphilis in an immunocompetent patient: A case report. | Neuropathology | 2024 |
| 36334050 | Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C. | Neuro Oncol | 2023 |
| 37530489 | The role of nonlinear dimension reduction of genome-wide DNA methylome in integrated diagnosis: A case study of glioblastoma, IDH-wildtype. | Pathol Int | 2023 |
| 37749662 | Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study. | Acta Neuropathol Commun | 2023 |
| 37744697 | Karnofsky Performance Status and quality of life in patients with relapsed or refractory primary CNS lymphoma from a phase I/II study of tirabrutinib. | Neurooncol Adv | 2023 |
| 37735187 | Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumors. | Sci Rep | 2023 |
| 37315111 | Increased PDGFRB and NF-κB signaling caused by highly prevalent somatic mutations in intracranial aneurysms. | Sci Transl Med | 2023 |
| 36843451 | Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults. | Neuro Oncol | 2023 |
| 34698864 | 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors. | Neuro Oncol | 2022 |
| 36428615 | Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study. | Cancers (Basel) | 2022 |
| 36198540 | [Molecular pathogenesis and therapeutic development of primary central nervous system lymphoma: update and future perspectives]. | Rinsho Ketsueki | 2022 |
| 36077758 | Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies. | Cancers (Basel) | 2022 |
| 35169086 | [Perspectives on Precision Medicine in Primary Central Nervous System Lymphoma]. | No Shinkei Geka | 2022 |
| 32583848 | Phase I/II study of tirabrutinib, a second-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma. | Neuro Oncol | 2021 |
| 33560416 | Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG). | Neuro Oncol | 2021 |
| 33808802 | Fine-Tuning Approach for Segmentation of Gliomas in Brain Magnetic Resonance Images with a Machine Learning Method to Normalize Image Differences among Facilities. | Cancers (Basel) | 2021 |
| 34615748 | [Treatment of Primary Central Nervous System Lymphoma: Standard Treatments According to the Japanese 2019 Guideline and Novel Treatments]. | Brain Nerve | 2021 |
| 34586548 | Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study. | Int J Clin Oncol | 2021 |
| 34523186 | Liquid biopsy of cerebrospinal fluid for MYD88 L265P mutation is useful for diagnosis of central nervous system lymphoma. | Cancer Sci | 2021 |
| 34609773 | Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial. | Cancer Sci | 2021 |
| 34549182 | Low tumor cell content predicts favorable prognosis in germinoma patients. | Neurooncol Adv | 2021 |
| 34020723 | Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study. | Acta Neuropathol Commun | 2021 |
| 34148105 | TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma. | Acta Neuropathol | 2021 |
| 34355172 | Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversy. | Neurooncol Adv | 2021 |
| 33411094 | Is using intracerebral hemorrhage scoring systems valid for mortality prediction in surgically treated patients? | Neurosurg Rev | 2021 |
| 32888020 | Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status. | Jpn J Clin Oncol | 2021 |
| 32989606 | Reduced H3K27me3 levels in diffuse gliomas: association with 1p/19q codeletion and difference from H3K27me3 loss in malignant peripheral nerve sheath tumors. | Brain Tumor Pathol | 2021 |
| 32818237 | So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma? | Neuro Oncol | 2021 |
| 31179566 | Intratumoural immune cell landscape in germinoma reveals multipotent lineages and exhibits prognostic significance. | Neuropathol Appl Neurobiol | 2020 |
| 33228806 | TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations. | Acta Neuropathol Commun | 2020 |
| 33365191 | Frontotemporal dermoid cyst with incomplete dermal sinus tract in an adult: A case report. | Surg Neurol Int | 2020 |
| 33067267 | A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma. | Cancer Res | 2020 |
| 32776443 | Utility of a bridged nucleic acid clamp for liquid biopsy: Detecting BRAF V600E in the cerebrospinal fluid of a patient with brain tumor. | Pediatr Blood Cancer | 2020 |
| 32469065 | Consecutive single-institution case series of primary central nervous system lymphoma treated by R-MPV or high-dose methotrexate monotherapy. | Jpn J Clin Oncol | 2020 |
| 32367437 | Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone. | J Neurooncol | 2020 |
| 30500939 | A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma. | Neuro Oncol | 2019 |
| 31420671 | Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium. | Neuro Oncol | 2019 |
| 30771771 | Detailed standardized protocol to prevent cerebrospinal fluid shunt infection. | J Neurosurg | 2019 |
| 31118432 | Publisher Correction: DNA demethylation is associated with malignant progression of lower-grade gliomas. | Sci Rep | 2019 |
| 31088845 | Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma. | Cancer Immunol Res | 2019 |
| 30760837 | DNA demethylation is associated with malignant progression of lower-grade gliomas. | Sci Rep | 2019 |
| 29258950 | MyD88 Mutation in Elderly Predicts Poor Prognosis in Primary Central Nervous System Lymphoma: Multi-Institutional Analysis. | World Neurosurg | 2018 |
| 30030187 | Hepatosplenic γδ T Cell Lymphoma Involving the Brain. | World Neurosurg | 2018 |
| 29924704 | Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial. | J Clin Oncol | 2018 |
| 30514397 | Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors. | Acta Neuropathol Commun | 2018 |
| 29373710 | Smart Glasses for Neurosurgical Navigation by Augmented Reality. | Oper Neurosurg (Hagerstown) | 2018 |
| 29557060 | JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma. | J Neurooncol | 2018 |
| 27231976 | Outcomes of chronic subdural hematoma with preexisting comorbidities causing disturbed consciousness. | J Neurosurg | 2017 |
| 28078450 | Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas. | Acta Neuropathol | 2017 |
| 28270234 | Genetic and epigenetic stability of oligodendrogliomas at recurrence. | Acta Neuropathol Commun | 2017 |